Briley Paul M, Boutry Clement, Webster Lucy, Veniero Domenica, Harvey-Seutcheu Catherine, Jung JeYoung, Liddle Peter F, Morriss Richard
Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Nottingham National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Nottingham, United Kingdom.
Imaging Neurosci (Camb). 2024 Jan 25;2. doi: 10.1162/imag_a_00073. eCollection 2024.
Repetitive transcranial magnetic stimulation (rTMS), delivered to left dorsolateral prefrontal cortex, is an FDA-approved, and NICE-recommended, neuromodulation therapy for major depressive disorder (MDD). However, there is considerable inter-individual variability in rate and extent of clinical response, leading to a focus on approaches for optimising its effectiveness. We present findings from a non-patient study evaluating an approach that combines an efficient type of rTMS-"intermittent theta burst stimulation" (iTBS)-with a second neuromodulation technique-"transcranial alternating current stimulation" (tACS). tACS is delivered in synchrony with the iTBS with the intent of optimising the brain state during stimulation. In four separate sessions, we delivered 3 minutes of iTBS+tACS, iTBS+sham, sham+tACS, or double sham. We measured changes from pre- to post-stimulation in brain theta (4-8 Hz) oscillatory activity using electroencephalography, and we measured emotional bias post-stimulation using a well-studied emotion identification task. Theta activity has previously shown relationships with response to rTMS, and emotional bias has been proposed as a marker of potential antidepressant efficacy. We found that frontal theta power was enhanced following the dual therapy, building up over the 15-minute post-stimulation period to exceed that following either stimulation technique alone or double sham. Emotional bias, measured 20 minutes post-stimulation, was also significantly more positive following dual therapy. These findings indicate that tACS-synchronised iTBS (tsiTBS) holds promise as an augmentation approach for rTMS, which awaits validation in multi-session patient studies.
重复经颅磁刺激(rTMS)作用于左侧背外侧前额叶皮层,是一种经美国食品药品监督管理局(FDA)批准且被英国国家卫生与临床优化研究所(NICE)推荐用于治疗重度抑郁症(MDD)的神经调节疗法。然而,临床反应的速度和程度存在相当大的个体差异,这导致人们将重点放在优化其疗效的方法上。我们展示了一项非患者研究的结果,该研究评估了一种将高效的rTMS类型——“间歇性theta爆发刺激”(iTBS)与另一种神经调节技术——“经颅交流电刺激”(tACS)相结合的方法。tACS与iTBS同步进行,目的是在刺激过程中优化脑状态。在四个独立的阶段中,我们分别进行了3分钟的iTBS+tACS、iTBS+假刺激、假刺激+tACS或双假刺激。我们使用脑电图测量了刺激前后脑theta(4 - 8Hz)振荡活动的变化,并使用一项经过充分研究的情绪识别任务测量了刺激后的情绪偏向。此前已表明theta活动与对rTMS的反应有关,并且情绪偏向已被提议作为潜在抗抑郁疗效的标志物。我们发现,双重治疗后额叶theta功率增强,在刺激后15分钟内逐渐增加,超过单独使用任何一种刺激技术或双假刺激后的水平。刺激后20分钟测量的情绪偏向在双重治疗后也明显更积极。这些发现表明,tACS同步iTBS(tsiTBS)有望作为rTMS的一种增效方法,这有待在多阶段患者研究中进行验证。